Search
Cognitive Impairment (CI)
go.drugbank.com/conditions/DBCOND0138824Drugs: PiracetamSynonyms: Disturbance in cognitionRelapsed Acute Myelogenous Leukemia (AML)
go.drugbank.com/conditions/DBCOND0069493Synonyms: Acute Myelogenous Leukemia in RelapseSleeping Disorders
go.drugbank.com/conditions/DBCOND0148601Synonyms: Disturbance in sleep behavior, NOS, Disturbance in sleep behavior (finding)Acyclovir
go.drugbank.com/drugs/DB00787ApprovedInvestigational[L7303,L7315,L7318,L7321,L7324,L7327] Acyclovir is generally used first line in the treatment of these viruses and some products are indicated for patients as young as 6 years old. … [L7321] Acyclovir was granted FDA approval on 29 March 1982.[L7318]
Products: AVIREX-I, ZOVIRAX IVFluocinolone acetonide
go.drugbank.com/drugs/DB00591ApprovedInvestigationalVet approved[T357] It has been used extensively in dermatological preparations and it has also been investigated thoroughly for its use in implantable corticosteroid devices. … [T358] This type of device containing fluocinolone acetonide was developed by Taro Pharmaceuticals and approved by FDA in May 2016.[L4676]
Mixtures: OCIDERM-N, CINOLON-NProducts: ILUVIEN 190 Mikrogramm intravitreales Implantat im ApplikatorFacial Angiofibroma
go.drugbank.com/conditions/DBCOND0063101Drugs: SirolimusSynonyms: Angiokeratoma in tuberous sclerosisDysuria
go.drugbank.com/conditions/DBCOND0004536Synonyms: Difficulty in voiding, Difficulty in urinationPovidone-iodine
go.drugbank.com/drugs/DB06812ApprovedInvestigationalDuring in vitro testing to demonstrate anti-bacterial activity it was found that the complex was less toxic in mice than tincture of iodine. … This unique complex was discovered in 1955 at the Industrial Toxicology Laboratories in Philadelphia by H. A. Shelanski and M. V. Shelanski.
Synonyms: PVP-IMixtures: BRAUNODERM (IN 250ML AND 1000ML PLASTIC), IV Infusion CPIMood Disorders
go.drugbank.com/conditions/DBCOND0027889Synonyms: Disturbance in affect, NOS, Disturbance in affect (finding)Mycophenolate mofetil
go.drugbank.com/drugs/DB00688ApprovedInvestigational[L7363] It is marketed by Roche Pharmaceuticals and was granted FDA approval for the prophylaxis of transplant rejection in 1995. … [A180826] In addition to the above uses, mycophenolate mofetil has also been studied for the treatment of nephritis and other complications of autoimmune diseases.
Products: CELLCEPT 500 MG IV İNFÜZYONLUK ÇÖZELTİ İÇİN TOZ, 4 ADET, Mycophenolatmofetil Accord 500 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung